Relation between some of risk factors and COVID-19 infection

Abstract

Several studies have now established that the hyperinflammatory response induced by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) is a major cause of disease severity and death in infected patients. In relation to the advent of the novel SARS-CoV-2, it has been shown that anti-SARS-CoV-2 IgM antibodies start to manifest one week after infection and last for one month before gradually waning. Contrarily, anti-SARS-CoV-2 IgG antibodies start to manifest 10–21 days after infection and seem to hold steady for as long as 3 months. IgM and IgG antibody levels in patients will be calculated using serologic assays. The enrolled subjects who were expected infect with SARS-CoV-2 were 106 among them, 49 (46.2 %) of the total number were positive for COVID-19, 19(54.3%) were males, 6(8.5%) were pregnant women and 24(33.8%) were non pregnant women while the rest of them 57 (53.8%) were negative by using ELISA. The age group 31-40 years old had the highest number of patients 20(60.6%). 33(67.3 percent) of patients had fever, 26(53.1%) headache, 15(30.69 %) couch, 21(42.8 %) of patients had shortness of breath, 10(20.8 %) diarrhea, 33(67.3 %) Tabification (exhaustion), and 3(6.1 %) O2 Low. high frequency of 17 cases and 12 cases in the A+ and B+ groups, respectively.